13 Feb 2023 by Ludwig Boltzmann
Congratulations to Dr. Barbara Peter on a new publication
We congratulate Dr. Barbara Peter on the publication of her work on the topic of targeted inhibition of the epigenetic reader BRD4.
Targeting the epigenetic reader BRD4 overcomes multiple forms of leukemic stem cell resistance in chronic myeloid leukemia and may be a novel therapeutic approach for therapy resistant CML patients.